Stay updated with breaking news from Nasdaq Beam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) and Biogen (NASDAQ:BIIB – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings & Valuation This table compares Beam Therapeutics and […]
Capital Impact Advisors LLC grew its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 3.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,600 shares of the company’s stock after buying an additional 445 shares during the quarter. Capital Impact […]
EcoR1 Capital LLC bought a new position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 198,591 shares of the company’s stock, valued at approximately $6,081,000. EcoR1 Capital LLC owned 0.27% of Beam Therapeutics […]
Cantor Fitzgerald reaffirmed their overweight rating on shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) in a report published on Tuesday morning, Benzinga reports. They currently have a $56.00 price objective on the stock. Other equities research analysts have also issued reports about the company. Wedbush restated an outperform rating and set a $79.00 price […]
Pearl River Capital LLC raised its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 37.9% in the 1st quarter, HoldingsChannel reports. The firm owned 14,676 shares of the company’s stock after buying an additional 4,036 shares during the period. Pearl River Capital LLC’s holdings in Beam Therapeutics were worth $449,000 as […]